145 related articles for article (PubMed ID: 38719948)
1. Alzheimer-like behavior and synaptic dysfunction in 3 × Tg-AD mice are reversed with calcineurin inhibition.
Zeng J; Hu XF; Sun DS; Hong XY; Ma JZ; Feng Q
Exp Brain Res; 2024 Jun; 242(6):1507-1515. PubMed ID: 38719948
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Cavallucci V; Berretta N; Nobili A; Nisticò R; Mercuri NB; D'Amelio M
Neuromolecular Med; 2013 Sep; 15(3):541-8. PubMed ID: 23821337
[TBL] [Abstract][Full Text] [Related]
3. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice.
Lin N; Pan XD; Chen AQ; Zhu YG; Wu M; Zhang J; Chen XC
Behav Brain Res; 2014 Jan; 258():8-18. PubMed ID: 24140565
[TBL] [Abstract][Full Text] [Related]
4. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.
Miller EC; Teravskis PJ; Dummer BW; Zhao X; Huganir RL; Liao D
Eur J Neurosci; 2014 Apr; 39(7):1214-24. PubMed ID: 24713000
[TBL] [Abstract][Full Text] [Related]
5. RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits.
Zhao D; Meng J; Zhao Y; Huo Y; Liu Y; Zheng N; Zhang M; Gao Y; Chen Z; Sun H; Wang X; Jing C; Zhang T; Zhang X; Luo H; Wang X; Zhang J; Liu FR; Li Y; Bu G; Wen L; Huang TY; Xu H; Zhang YW
Biol Psychiatry; 2019 Aug; 86(3):171-184. PubMed ID: 30292394
[TBL] [Abstract][Full Text] [Related]
6. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition.
Taglialatela G; Hogan D; Zhang WR; Dineley KT
Behav Brain Res; 2009 Jun; 200(1):95-9. PubMed ID: 19162087
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-induced enhancement of synaptic plasticity at CA3-CA1 synapses requires GABAergic interneurons in adult anti-NGF mice.
Rosato-Siri M; Cattaneo A; Cherubini E
J Physiol; 2006 Oct; 576(Pt 2):361-77. PubMed ID: 16873411
[TBL] [Abstract][Full Text] [Related]
8. Blockade of adenosine A
Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
10. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
13. Exploring Dimethylsulfoniopropionate as a potential treatment for Alzheimer's disease: A study using the 3 × Tg-AD mouse model.
Sun F; Huang X; Wang H; Lin B; Li H; Wang X; Liu Q
Phytomedicine; 2024 Jul; 130():155788. PubMed ID: 38838634
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Na
Moriguchi S; Kita S; Fukaya M; Osanai M; Inagaki R; Sasaki Y; Izumi H; Horie K; Takeda J; Saito T; Sakagami H; Saido TC; Iwamoto T; Fukunaga K
Neuropharmacology; 2018 Mar; 131():291-303. PubMed ID: 29274751
[TBL] [Abstract][Full Text] [Related]
15. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model.
Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
J Neurosci; 2013 May; 33(19):8423-41. PubMed ID: 23658180
[TBL] [Abstract][Full Text] [Related]
16. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling.
Yin Y; Gao D; Wang Y; Wang ZH; Wang X; Ye J; Wu D; Fang L; Pi G; Yang Y; Wang XC; Lu C; Ye K; Wang JZ
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3773-81. PubMed ID: 27298345
[TBL] [Abstract][Full Text] [Related]
17. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.
Jiang Y; Li K; Li X; Xu L; Yang Z
Chem Biol Interact; 2021 May; 341():109452. PubMed ID: 33785315
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice.
Rozkalne A; Hyman BT; Spires-Jones TL
Neurobiol Dis; 2011 Mar; 41(3):650-4. PubMed ID: 21134458
[TBL] [Abstract][Full Text] [Related]
20. Selenium Restores Synaptic Deficits by Modulating NMDA Receptors and Selenoprotein K in an Alzheimer's Disease Model.
Zhang ZH; Chen C; Jia SZ; Cao XC; Liu M; Tian J; Hoffmann PR; Xu HX; Ni JZ; Song GL
Antioxid Redox Signal; 2021 Oct; 35(11):863-884. PubMed ID: 32475153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
